Seminal hemostatic factors: Then and now

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 1, 2007, Pages 3-12

  Lwaleed, Bashir A ^a   Goyal, Anuj ^b   Delves, George H ^b   Cooper, Alan J ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Coagulation; Hemostatic factors; Human semen; Liquefaction

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9A; FIBRIN; FIBRINOGEN; PROTEINASE INHIBITOR; PROTHROMBIN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ANTIINFLAMMATORY ACTIVITY; BLEEDING; BLOOD CLOTTING; EJACULATION; FIBRINOLYSIS; HEMOSTASIS; LIQUEFACTION; MALE FERTILITY; MALE INFERTILITY; PRIORITY JOURNAL; REVIEW; SEMINAL VESICLE; SPERM; SPERMATOZOON CAPACITATION;

BLOOD COAGULATION FACTORS; FERTILITY; FIBRINOLYSIS; HEMOSTATICS; HUMANS; INFERTILITY, MALE; MALE; SEMEN; SEMINAL PLASMA PROTEINS;

EID: 33846599759     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-958456     Document Type: Review

References (71)

1. Masaki J. Biochemistry of semen. In: Mohri H, Morisawa M, Hoshi M, eds. Spermatology. Tokyo: University of Tokyo Press; 1992:121-137
2. Huggins C, Neal W. Coagulation and liquefaction of semen. Proteolytic enzymes and citrate in prostatic fluid. J Exp Med 1942;76:527-541
3. Fareed J, Callas DD, Hoppensteadt D, Bermes EW Jr. Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinolysis 1995;6(Suppl 1):32-36
4. Fernández JA, Heeb MJ, Radtke K-P, Griffin JH. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor. Biol Reprod 1997;56:757-763
5. Notides AC, Williams-Ashman HG. The basic proteins responsible for clotting of guinea pig semen. Proc Natl Acad Sci USA 1967;58:1991-1995
6. van Wersch JWJ, de Vries-Hanje JC, Ubachs JMH. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness. Eur J Clin Chem Clin Biochem 1992;30:467-471
7. Park JY, Yoshimara Y, Nozawa S, Umeda T, Akihama S, Matsuda Y. Fibrinogen-like substance and thrombin like enzyme in human seminal plasma: coagulation of human semen. Arch Androl 1997;38:29-36
8. Carson SD, de-Jonge CJ. Activation of coagulation factor X in human semen. J Androl 1998;19:289-294
9. Polak B, Daunter B. Seminal plasma biochemistry. IV: enzymes involved in the liquefaction of human seminal plasma. Int J Androl 1989;12:187-194
10. Mandal A, Batabyal SK, Bhattacharyya AK. Glycerylphosphorylcholine levels in the coagulational groups of human ejaculates. Indian J Med Res 1989;90:186-190
11. Minhas BS, Kumar R, Ricker DD, Roudebush WE, Dodson MG, Fortunate SJ. Effects of platelet activating factor on mouse oocyte fertilization in vitro. Am J Obstet Gynecol 1989;161:1714-1717
12. MacGregor IR, Hargreave TB, Elton RA. Seminal plasma plasminogen activator and fertility. Andrologia 1987;19:452-455
13. van Dreden P, Gonzales J, Richard P. Determination of tissue plasminogen activator (t-PA) antigen in seminal plasma by modified enzyme-linked immunosorbant assay (ELISA). Andrologia 1988;20:48-51
14. van Dreden P, Gonzalez J, Poirot C. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase. Andrologia 1991;23: 29-33
15. España F, Gilabert J, Estellés A, Romeu A, Aznar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhlbitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991; 64:309-320
16. Lwaleed BA, Greenfield RS, Steward AB, Birch BR, Cooper AJ. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost 2004;92:752-766
17. Matsuda Y, Shimokawa K, Katayama M, et al. Blood coagulation factor X (FX) in human seminal plasma. Arch Androl 2002;48:295-300
18. Lwaleed BA, Greenfield RS, Hicks J, Birch BR, Cooper AJ. Quantitation of seminal factor IX and factor IXa in fertile, non-fertile and vasectomy subjects: a step closer towards identifying a functional clotting system in human semen. J Androl 2005;26:146-152
19. Lwaleed BA, Greenfield RS, Royle E, Birch BR, Cooper AJ. Seminal factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen? Int J Androl 2005;28:31-38
20. Lwaleed BA, Greenfield RS, Birch BR, Cooper AJ. Does human semen contain a functional haemostatic system? A possible role for tissue factor pathway inhibitor in fertility through semen liquefaction. Thromb Haemost 2005;93:847-852
21. Lwaleed BA, Jackson C, Greenfield RS, et al. Seminal tissue factor revisited. Int J Androl 2006;29:360-367
22. Tauber PF, Zaneveld LJD, Propping D, Schumacher GF. A new technique to measure the liquefaction rate of human semen: the bag method. Fertil Steril 1980;33:567-570
23. Wetterauer U. Recommended biochemical parameters for routine semen analysis. Urol Res 1986;14:241-246
24. Mandal A, Bhattacharyya AK. Grouping of human ejaculates according to the degree of coagulation and the relationship to the levels of choline and cholinesterase. Int J Androl 1986; 9:407-415
25. Syner FN, Moghissi KS, Yanez J. Isolation of a factor from normal human semen that accelerates dissolution of abnormally liquefying semen. Fertil Steril 1975;26:1064-1069
26. Lukac J, Koren E. Mechanism of liquefaction of the human ejaculate. II. Role of collagenase-like peptidase and seminal proteinase. J Reprod Fertil 1979;56:501-506
27. Ohta S, Wada H, Gabazza EC, Nobori T, Fuse H. Evaluation of tissue factor antigen level in human seminal plasma. Urol Res 2002;30:317-320
28. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992;89(4):1094-1101
29. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992;89:1094-1101
30. Bronson RA, Preissner KT. Measurement of vitronectin content of human spermatozoa and vitronectin concentration within seminal fluid. Fertil Steril 1997;68:709-713
31. Preissner KT, Seiffert D. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 1998; 89:1-21
32. Schvartz I, Seger D, Shaltiel S. Vitronectin. Int J Biochem Cell Biol 1999;31:539-544
33. Kirchheimer JC, Hienert G, Christ G, Binder BR. Components of the fibrinolytic system in spermatozoa and seminal plasma of fertile and infertile men. Thromb Haemost 1989;62:396 (abst)
34. Williams-Ashman HG, Notides AC, Pabalan SS, Lorand L. Transamidase reactions involved in the enzymic coagulation of semen: isolation of -glutamyl-lysine dipeptide from clotted secretion protein of guinea pig seminal vesicle. Proc Natl Acad Sci U S A 1972;69:2322-2325
35. Williams-Ashman HG, Wilson J, Beil RE, Lorand L. Transglutaminase reactions associated with the rat semen clotting system: modulation by macromolecular polyanions. Biochem Biophys Res Commun 1977;79:1192-1198
36. Tauber PF, Zaneveld LJD, Propping D, Schumacher GFB. Components of human split ejaculates. II. Enzymes and proteinase inhibitors. J Reprod Fertil 1976;46:165-171
37. Murakami J, Yoshiike M, Satoh M, Furuichi Y, Iwamoto T. Characterization of recombinant precursor proteins of the human seminal plasma sperm motility inhibitor synthesized in insect cells. Int J Mol Med 1998;2:693-700
38. Peter A, Lilja H, Lundwall A, Malm J. Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase. Eur J Biochem 1998;252:216-221
39. Chaistitvanich N, Boonsaeng V. Molecular structure of human seminal coagulum: the role of disulfide bonds. Andrologia 1983;15:446-451
40. Lilja H, Laurell CB. Liquefaction of coagulated human semen. Scand J Clin Lab Invest 1984;44:447-452
41. Lilja H, Laurell CB. The predominant protein in human seminal coagulate. Scand J Clin Lab Invest 1985;45:635-641
42. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-1903
43. Malm J, Hellman J, Hogg P, Lilja H. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn (2+), a tight-binding inhibitor. Prostate 2000;45:132-139
44. Laurell CB, Weiber H, Ohlsson K, Rannevik G. A zinc-dependent peptidase in prostatic organelles present in seminal plasma. Clin Chim Acta 1982;126:161-170
45. Mann T. The Biochemistry of Semen and of the Male Reproductive Tract. London: Methuen; 1984
46. Edwards JJ, Tollaksen SI, Andersson NG. Proteins of human semen. 1. Two-dimensional mapping of human seminal fluid. Clin Chem 1981;27:1335-1340
47. Lilja H, Laurell CB, Jeppsson JO. Characterization of the predominant basic protein in human seminal plasma, one cleavage product of the major seminal vesicle protein. Scand J Clin Lab Invest 1984;44:439-446
48. Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta 1985;822:203-218
49. Brody I, Ronquist G, Gottfries A. Ultrastructural localisation of the prostasome-an organelle in human seminal plasma. Ups J Med Sci 1983;88:63-80
50. Thyzel E, Siegling S, Getting C, Tinneberg HR, Brinkmann T, Kleesiek K. Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid. Thromb Res 2003;109:329-332
51. Yamamuro M, Wada H, Kumeda K, et al. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1998;9:491-497
52. Moghissi KS, Wallach EE. Unexplained infertility. Fertil Steril 1983;39:5-21
53. Elzanaty S, Richthoff J, Malm J, et al. The impact of epididymal and accessory sex gland function on sperm motility. Hum Reprod 2002;17:2904-2911
54. Zhao Y, Vlahos N, Wyncott D, et al. Impact of semen characteristics on the success of intrauterine insemination. J Assist Reprod Genet 2004;21:143-148
55. Skibinski G, Kelley RW, Harkiss D, James K. Immunosuppression by human seminal plasma-extracellular organelles (prostasomes) modulate activity of phagocytic cells. Am J Reprod Immunol 1992;28:97-103
56. Ronquist G, Nilsson BO, Hjertën S. Interaction between prostasomes and spermatozoa from human semen. Arch Androl 1990;24:147-157
57. Arienti G, Carlini E, Palmerini CA. Fusion of human sperm to prostasomes at acidic pH. J Membr Biol 1997;155: 89-94
58. Federici AB. The factor VIII/von Willebrand factor complex: basic and clinical issues (EREP02). Haematologica 2003;88: 3-12
59. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000;95:3678-3682
60. Reiner AP, Davie EW. The physiology and biochemistry of factor IX. In: Bloom AL, Thomas DP eds. Haemostasis and Thrombosis. 3rd ed. Edinburgh: Churchill Livingstone; 1994:309-324
61. van Wersch JWJ, Ubachs JHM, Dalaere KPJ. Fibrinolysis and coagulation markers in seminal plasma before and after vasectomy. Fibrinolysis 1993;7:135-138
62. Matsuda Y, Oshio S, Yazaki T, Umeda T, Akihama S. The effect of some proteinase inhibitors on liquefaction of human semen. Hum Reprod 1994;9:664-668
63. Maier U, Kirchheimer JC, Hienert G, Christ G, Binder BR. Fibrinolytic parameters in spermatozoas and seminal plasma. J Urol 1991;146:906-908
64. Zhang GH. Preliminary studies on the role of plasminogen activator in seminal plasma of human and rhesus monkey. Mol Hum Reprod 1996;2:99-104
65. Lwaleed BA, Goyal A, Delves G, Greenfield RS, Cooper AJ. Quantification of seminal thrombomodulin. Haematologica 2006;91:391(Abst)
66. Lwaleed BA, Greenfield RS, Birch BR, Cooper AJ. Quantitation of thrombin activatable fibrinolysis inhibitor (TAFI) in human semen. Br J Haematol 2005;129(Suppl 1): 173 (Abst)
67. Robert M, Gagnon C. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein. Cell Mol Life Sci 1999;55:944-960
68. Dietl T, Kruch J, Schill WB, Fritz H. Localization of seminal plasma proteinase inhibitors in human spermatozoa as revealed by indirect immunofluorescence technique. Hoppe Seylers Z Physiol Chem 1976;357:1333-1337
69. Veselsky L, Jonakova V, Cechova D. A Kunitz type of proteinase inhibitor isolated from boar seminal vesicle fluid. Andrologia 1985;17:352-358
70. Hara I, Matsuda Y, Kaneko S, et al. Human seminal plasma proteinase inhibitor: action toward some trypsin-like arginine amidases from humans. Arch Androl 1993;31:23-29
71. Rümke P. The origin of immunoglobulins in semen. Clin Exp Immunol 1974;17:287-297